[{"indications": "Indications\u00a0treatment of mild to moderate Pneumocystis jirovecii (Pneumocystis carinii) pneumonia\r\nin patients intolerant of co-trimoxazole", "name": "ATOVAQUONE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.4 Antiprotozoal drugs", "5.4.8 Drugs for pneumocystis pneumonia", "ATOVAQUONE"], "cautions": "Cautions\u00a0initial diarrhoea and difficulty in taking with food may reduce absorption\r\n(and require alternative therapy); other causes of pulmonary\r\ndisease should be sought and treated; elderly; interactions: Appendix 1 (atovaquone)", "side-effects": "Side-effects\u00a0nausea, diarrhoea, vomiting; headache, insomnia;\r\nfever; anaemia, neutropenia, hyponatraemia; rash, pruritus; also reported,\r\nStevens-Johnson syndrome", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/27973.htm", "doses": ["750\u00a0mg twice daily with food (particularly high fat) for\r\n21 days; child not recommended"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless potential benefit\r\noutweighs risk\u2014no information available"}]